Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 63
Filter
1.
Blood ; 143(22): 2224-2225, 2024 May 30.
Article in English | MEDLINE | ID: mdl-38814656
2.
Int J Mol Sci ; 23(16)2022 Aug 18.
Article in English | MEDLINE | ID: mdl-36012554

ABSTRACT

Enhancers in higher eukaryotes and upstream activating sequences (UASs) in yeast have been shown to recruit components of the RNA polymerase II (Pol II) transcription machinery. At least a fraction of Pol II recruited to enhancers in higher eukaryotes initiates transcription and generates enhancer RNA (eRNA). In contrast, UASs in yeast do not recruit transcription factor TFIIH, which is required for transcription initiation. For both yeast and mammalian systems, it was shown that Pol II is transferred from enhancers/UASs to promoters. We propose that there are two modes of Pol II recruitment to enhancers in higher eukaryotes. Pol II complexes that generate eRNAs are recruited via TFIID, similar to mechanisms operating at promoters. This may involve the binding of TFIID to acetylated nucleosomes flanking the enhancer. The resulting eRNA, together with enhancer-bound transcription factors and co-regulators, contributes to the second mode of Pol II recruitment through the formation of a transcription initiation domain. Transient contacts with target genes, governed by proteins and RNA, lead to the transfer of Pol II from enhancers to TFIID-bound promoters.


Subject(s)
Enhancer Elements, Genetic , Saccharomyces cerevisiae , Animals , Mammals/metabolism , RNA , RNA Polymerase II/metabolism , Saccharomyces cerevisiae/metabolism , Transcription Factor TFIID/genetics , Transcription Factor TFIID/metabolism , Transcription, Genetic
3.
Blood ; 138(18): 1648-1649, 2021 11 04.
Article in English | MEDLINE | ID: mdl-34735000
4.
Front Mol Biosci ; 8: 681550, 2021.
Article in English | MEDLINE | ID: mdl-34055891

ABSTRACT

Transcription by RNA polymerase II (Pol II) is regulated by different processes, including alterations in chromatin structure, interactions between distal regulatory elements and promoters, formation of transcription domains enriched for Pol II and co-regulators, and mechanisms involved in the initiation, elongation, and termination steps of transcription. Transcription factor TFII-I, originally identified as an initiator (INR)-binding protein, contains multiple protein-protein interaction domains and plays diverse roles in the regulation of transcription. Genome-wide analysis revealed that TFII-I associates with expressed as well as repressed genes. Consistently, TFII-I interacts with co-regulators that either positively or negatively regulate the transcription. Furthermore, TFII-I has been shown to regulate transcription pausing by interacting with proteins that promote or inhibit the elongation step of transcription. Changes in TFII-I expression in humans are associated with neurological and immunological diseases as well as cancer. Furthermore, TFII-I is essential for the development of mice and represents a barrier for the induction of pluripotency. Here, we review the known functions of TFII-I related to the regulation of Pol II transcription at the stages of initiation and elongation.

5.
Nucleic Acids Res ; 49(10): 5779-5797, 2021 06 04.
Article in English | MEDLINE | ID: mdl-34048572

ABSTRACT

Faithful genome integrity maintenance plays an essential role in cell survival. Here, we identify the RNA demethylase ALKBH5 as a key regulator that protects cells from DNA damage and apoptosis during reactive oxygen species (ROS)-induced stress. We find that ROS significantly induces global mRNA N6-methyladenosine (m6A) levels by modulating ALKBH5 post-translational modifications (PTMs), leading to the rapid and efficient induction of thousands of genes involved in a variety of biological processes including DNA damage repair. Mechanistically, ROS promotes ALKBH5 SUMOylation through activating ERK/JNK signaling, leading to inhibition of ALKBH5 m6A demethylase activity by blocking substrate accessibility. Moreover, ERK/JNK/ALKBH5-PTMs/m6A axis is activated by ROS in hematopoietic stem/progenitor cells (HSPCs) in vivo in mice, suggesting a physiological role of this molecular pathway in the maintenance of genome stability in HSPCs. Together, our study uncovers a molecular mechanism involving ALKBH5 PTMs and increased mRNA m6A levels that protect genomic integrity of cells in response to ROS.


Subject(s)
AlkB Homolog 5, RNA Demethylase/metabolism , DNA Damage , DNA Repair , Reactive Oxygen Species/metabolism , AlkB Homolog 5, RNA Demethylase/genetics , Animals , Apoptosis/drug effects , Apoptosis/genetics , Bone Marrow Cells/drug effects , Bone Marrow Cells/metabolism , Cell Line, Tumor , DNA Damage/drug effects , DNA Repair/drug effects , DNA Repair/genetics , Demethylation/drug effects , Fanconi Anemia Complementation Group Proteins/genetics , Fanconi Anemia Complementation Group Proteins/metabolism , Gene Expression Regulation/drug effects , Gene Expression Regulation/genetics , Hematopoietic Stem Cells/drug effects , Hematopoietic Stem Cells/metabolism , Humans , Hydrogen Peroxide/pharmacology , MAP Kinase Signaling System/drug effects , Methylation/drug effects , Mice , Phosphorylation , Protein Processing, Post-Translational , RNA, Small Interfering , RNA-Binding Proteins/genetics , RNA-Binding Proteins/metabolism , RNA-Seq , Sumoylation/drug effects , Tandem Mass Spectrometry , X-linked Nuclear Protein/genetics , X-linked Nuclear Protein/metabolism
6.
Mol Ther ; 29(6): 1933-1934, 2021 06 02.
Article in English | MEDLINE | ID: mdl-33961803
7.
Nucleic Acids Res ; 49(3): 1383-1396, 2021 02 22.
Article in English | MEDLINE | ID: mdl-33476375

ABSTRACT

Super-enhancers (SEs) mediate high transcription levels of target genes. Previous studies have shown that SEs recruit transcription complexes and generate enhancer RNAs (eRNAs). We characterized transcription at the human and murine ß-globin locus control region (LCR) SE. We found that the human LCR is capable of recruiting transcription complexes independently from linked globin genes in transgenic mice. Furthermore, LCR hypersensitive site 2 (HS2) initiates the formation of bidirectional transcripts in transgenic mice and in the endogenous ß-globin gene locus in murine erythroleukemia (MEL) cells. HS2 3'eRNA is relatively unstable and remains in close proximity to the globin gene locus. Reducing the abundance of HS2 3'eRNA leads to a reduction in ß-globin gene transcription and compromises RNA polymerase II (Pol II) recruitment at the promoter. The Integrator complex has been shown to terminate eRNA transcription. We demonstrate that Integrator interacts downstream of LCR HS2. Inducible ablation of Integrator function in MEL or differentiating primary human CD34+ cells causes a decrease in expression of the adult ß-globin gene and accumulation of Pol II and eRNA at the LCR. The data suggest that transcription complexes are assembled at the LCR and transferred to the globin genes by mechanisms that involve Integrator mediated release of Pol II and eRNA from the LCR.


Subject(s)
Enhancer Elements, Genetic , Gene Expression Regulation , RNA/metabolism , Transcription, Genetic , beta-Globins/genetics , Adult , Animals , Cell Line, Tumor , Endoribonucleases/genetics , Fetus , Humans , Liver/embryology , Liver/metabolism , Locus Control Region , Mice, Transgenic , RNA/physiology , RNA Polymerase II/metabolism , beta-Globins/biosynthesis
8.
Front Physiol ; 11: 590180, 2020.
Article in English | MEDLINE | ID: mdl-33101065

ABSTRACT

TFII-I is a ubiquitously expressed transcription factor that positively or negatively regulates gene expression. TFII-I has been implicated in neuronal and immunologic diseases as well as in thymic epithelial cancer. Williams-Beuren Syndrome (WBS) is caused by a large hemizygous deletion on chromosome 7q11.23 which encompasses 26-28 genes, including GTF2I, the human gene encoding TFII-I. A subset of WBS patients has recently been shown to present with macrocytosis, a mild anemia characterized by enlarged erythrocytes. We conditionally deleted the TFII-I/Gtf2i gene in adult mice by tamoxifen induced Cre-recombination. Bone marrow cells revealed defects in erythro-megakaryopoiesis and an increase in expression of the adult ß-globin gene. The data show that TFII-I acts as a repressor of ß-globin gene transcription and that it is implicated in the differentiation of erythro-megakaryocytic cells.

9.
Emerg Top Life Sci ; 4(3): 281-291, 2020 12 11.
Article in English | MEDLINE | ID: mdl-32338276

ABSTRACT

Genes under control of super-enhancers are expressed at extremely high levels and are frequently associated with nuclear speckles. Recent data suggest that the high concentration of unphosphorylated RNA polymerase II (Pol II) and Mediator recruited to super-enhancers create phase-separated condensates. Transcription initiates within or at the surface of these phase-separated droplets and the phosphorylation of Pol II, associated with transcription initiation and elongation, dissociates Pol II from these domains leading to engagement with nuclear speckles, which are enriched with RNA processing factors. The transitioning of Pol II from transcription initiation domains to RNA processing domains effectively co-ordinates transcription and processing of highly expressed RNAs which are then rapidly exported into the cytoplasm.


Subject(s)
RNA Polymerase II , Transcription, Genetic , Phosphorylation , RNA Polymerase II/genetics , RNA Polymerase II/metabolism
10.
Sci Adv ; 6(8): eaaw4651, 2020 02.
Article in English | MEDLINE | ID: mdl-32128389

ABSTRACT

Chromatin topological organization is instrumental in gene transcription. Gene-enhancer interactions are accommodated in the same CTCF-mediated insulated neighborhoods. However, it remains poorly understood whether and how the 3D genome architecture is dynamically restructured by external signals. Here, we report that LATS kinases phosphorylated CTCF in the zinc finger (ZF) linkers and disabled its DNA-binding activity. Cellular stress induced LATS nuclear translocation and CTCF ZF linker phosphorylation, and altered the landscape of CTCF genomic binding partly by dissociating it selectively from a small subset of its genomic binding sites. These sites were highly enriched for the boundaries of chromatin domains containing LATS signaling target genes. The stress-induced CTCF phosphorylation and locus-specific dissociation from DNA were LATS-dependent. Loss of CTCF binding disrupted local chromatin domains and down-regulated genes located within them. The study suggests that external signals may rapidly modulate the 3D genome by affecting CTCF genomic binding through ZF linker phosphorylation.


Subject(s)
CCCTC-Binding Factor/metabolism , Protein Kinases/metabolism , Binding Sites , CCCTC-Binding Factor/chemistry , Chromatin/genetics , Chromatin/metabolism , Genomics/methods , Humans , Lipoproteins/metabolism , Models, Biological , Phosphorylation , Protein Binding , Signal Transduction , Stress, Physiological , Zinc Fingers
12.
Mol Ther Methods Clin Dev ; 12: 102-110, 2019 Mar 15.
Article in English | MEDLINE | ID: mdl-30603654

ABSTRACT

Hemoglobinopathies, including sickle cell disease and thalassemia, are among the most common inherited genetic diseases worldwide. Due to the relative ease of isolating and genetically modifying hematopoietic stem and progenitor cells, recent gene editing and gene therapy strategies have progressed to clinical trials with promising outcomes; however, challenges remain and necessitate the continued exploration of new gene engineering and cell transplantation protocols. Current gene engineering strategies aim at reactivating the expression of the fetal γ-globin genes in adult erythroid cells. The γ-globin proteins exhibit anti-sickling properties and can functionally replace adult ß-globin. Here, we describe and compare the current genetic engineering procedures that may develop into safe and efficient therapies for hemoglobinopathies in the near future.

13.
Bioessays ; 41(1): e1800164, 2019 01.
Article in English | MEDLINE | ID: mdl-30500078

ABSTRACT

It is proposed that the multiple enhancer elements associated with locus control regions and super-enhancers recruit RNA polymerase II and efficiently assemble elongation competent transcription complexes that are transferred to target genes by transcription termination and transient looping mechanisms. It is well established that transcription complexes are recruited not only to promoters but also to enhancers, where they generate enhancer RNAs. Transcription at enhancers is unstable and frequently aborted. Furthermore, the Integrator and WD-domain containing protein 82 mediate transcription termination at enhancers. Abortion and termination of transcription at the multiple enhancers of locus control regions and super-enhancers provide a large pool of elongation competent transcription complexes. These are efficiently captured by strong basal promoter elements at target genes during transient looping interactions.


Subject(s)
Enhancer Elements, Genetic , Gene Expression Regulation , Locus Control Region , RNA Polymerase II/metabolism , Transcription, Genetic , Humans , beta-Globins/genetics
14.
Mol Cell Biol ; 38(19)2018 10 01.
Article in English | MEDLINE | ID: mdl-30012865

ABSTRACT

The organization of the five ß-type globin genes on chromosome 11 reflects the timing of expression during erythroid cell development, with the embryonic ε-globin gene being located at the 5' end, followed by the two fetal γ-globin genes, and with the adult ß- and δ-globin genes being located at the 3' end. Here, we functionally characterized a DNase I-hypersensitive site (HS) located 4 kb upstream of the Gγ-globin gene (HBG-4kb HS). This site is occupied by transcription factors USF1, USF2, EGR1, MafK, and NF-E2 in the human erythroleukemia cell line K562 and exhibits histone modifications typical for enhancers. We generated a synthetic zinc finger (ZF) DNA-binding domain targeting the HBG-4kb HS (HBG-4kb ZF). The HBG-4kb ZF interacted with the target site in vitro and in the context of cells with a high affinity and specificity. Direct delivery of the HBG-4kb ZF to K562 and primary human erythroid cells caused a reduction in γ-globin gene expression which was associated with decreased binding of transcription factors and active histone marks at and downstream of the HS. The data demonstrate that the HBG-4kb HS is important for fetal globin production and suggest that it may act by opening chromatin in a directional manner.


Subject(s)
Chromatin/genetics , gamma-Globins/genetics , Deoxyribonuclease I , Enhancer Elements, Genetic , Erythropoiesis/genetics , Gene Expression Regulation, Developmental , Genes, Switch , Histone Code/genetics , Humans , K562 Cells , Models, Genetic , Polymorphism, Single Nucleotide , RNA/genetics , RNA/metabolism , gamma-Globins/metabolism
16.
Peptides ; 104: 1-6, 2018 06.
Article in English | MEDLINE | ID: mdl-29635062

ABSTRACT

In short-term animal models of ischemia, erythropoietin (EPO) signaling through the heterodimeric EPO receptor (EPOR)/ß-common receptor (ßCR) is believed to elicit tissue protective effects. However, large, randomized, controlled trials demonstrate that targeting a higher hemoglobin level by administering higher doses of EPO, which are more likely to activate the heterodimeric EPOR/ßCR, is associated with an increase in adverse cardiovascular events. Thus, inhibition of long-term activation of the ßCR may have therapeutic implications. This study aimed to design and evaluate the efficacy of novel computationally designed ßCR inhibitory peptides (ßIP). These novel ßIPs were designed based on a truncated portion of Helix-A from EPO, specifically residues 11-26 (VLERYLLEAKEAEKIT). Seven novel peptides (P1 to P7) were designed. Peptide 7 (P7), VLERYLHEAKHAEKIT, demonstrated the most robust inhibitory activity. We also report here the ability of P7 to inhibit ßCR-induced nitric oxide (NO) production and angiogenesis in human umbilical vein endothelial cells (HUVECs). Specifically, we found that P7 ßIP completely abolished EPO-induced NO production. The inhibitory effect could be overcome with super physiological doses of EPO, suggesting a competitive inhibition. ßCR-induced angiogenesis in HUVEC's was also abolished with treatment of P7 ßIP, but P7 ßIP did not inhibit vascular endothelial growth factor (VEGF)-induced angiogenesis. In addition, we demonstrate that the novel P7 ßIP does not inhibit EPO-induced erythropoiesis with use of peripheral blood mononuclear cells (PBMCs). These results, for the first time, describe a novel, potent ßCR peptide inhibitor that inhibit the actions of the ßCR without affecting erythropoiesis.


Subject(s)
Cytokine Receptor Common beta Subunit/metabolism , Erythropoietin/pharmacology , Peripheral Blood Stem Cells/metabolism , Signal Transduction/physiology , Amino Acid Sequence , Cells, Cultured , Computational Biology , Human Umbilical Vein Endothelial Cells , Humans , Molecular Sequence Data , Nitric Oxide/metabolism , Peripheral Blood Stem Cells/drug effects , Protein Structure, Secondary , Signal Transduction/genetics
17.
J Cell Biochem ; 119(1): 712-722, 2018 01.
Article in English | MEDLINE | ID: mdl-28657656

ABSTRACT

Transcription factor TFII-I is a multifunctional protein implicated in the regulation of cell cycle and stress-response genes. Previous studies have shown that a subset of TFII-I associated genomic sites contained DNA-binding motifs for E2F family transcription factors. We analyzed the co-association of TFII-I and E2Fs in more detail using bioinformatics, chromatin immunoprecipitation, and co-immunoprecipitation experiments. The data show that TFII-I interacts with E2F transcription factors. Furthermore, TFII-I, E2F4, and E2F6 interact with DNA-regulatory elements of several genes implicated in the regulation of the cell cycle, including DNMT1, HDAC1, CDKN1C, and CDC27. Inhibition of TFII-I expression led to a decrease in gene expression and in the association of E2F4 and E2F6 with these gene loci in human erythroleukemia K562 cells. Finally, TFII-I deficiency reduced the proliferation of K562 cells and increased the sensitivity toward doxorubicin toxicity. The results uncover novel interactions between TFII-I and E2Fs and suggest that TFII-I mediates E2F function at specific cell cycle genes.


Subject(s)
Cell Cycle Proteins/genetics , E2F Transcription Factors/metabolism , Transcription Factors, TFII/metabolism , Cell Cycle , Cell Proliferation , Chromatin Immunoprecipitation , Computational Biology/methods , E2F Transcription Factors/genetics , Humans , K562 Cells , Promoter Regions, Genetic , Protein Binding , Transcription Factors, TFII/genetics
18.
Methods Mol Biol ; 1654: 361-375, 2017.
Article in English | MEDLINE | ID: mdl-28986805

ABSTRACT

Zinc finger proteins are the most common among families of DNA-binding transcription factors. Designer transcription factors generated by the fusion of engineered zinc finger DNA-binding domains (ZF-DBDs) to effector domains have been valuable tools for the modulation of gene expression and for targeted genome editing. However, ZF-DBDs without effector domains have also been shown to effectively modulate gene expression by competing with sequence-specific DNA-binding transcription factors. Here, we describe the methodology and provide a detailed workflow for the cloning, expression, purification, and direct cell delivery of engineered ZF-DBDs. Using this protocol, ZF-DBDs can be generated with high efficiency in less than 2 weeks. We also describe a nonradioactive method for measuring DNA binding affinity of the purified ZF-DBD proteins as well as a method for direct delivery of the purified ZF-DBDs to mammalian cells.


Subject(s)
DNA-Binding Proteins/metabolism , Transcription Factors/metabolism , Animals , Binding Sites , DNA-Binding Proteins/chemistry , Electrophoretic Mobility Shift Assay , Humans , Protein Binding , Recombinant Proteins/genetics , Recombinant Proteins/metabolism , Transcription Factors/chemistry , Zinc Fingers
20.
Mol Ther Nucleic Acids ; 5(10): e378, 2016 Oct 18.
Article in English | MEDLINE | ID: mdl-27754490

ABSTRACT

Reactivation of γ-globin expression has been shown to ameliorate disease phenotypes associated with mutations in the adult ß-globin gene, including sickle cell disease. Specific mutations in the promoter of the γ-globin genes are known to prevent repression of the genes in the adult and thus lead to hereditary persistence of fetal hemoglobin. One such hereditary persistence of fetal hemoglobin is associated with a sequence located 567 bp upstream of the Gγ-globin gene which assembles a GATA-containing repressor complex. We generated two synthetic zinc-finger DNA-binding domains (ZF-DBDs) targeting this sequence. The -567Gγ ZF-DBDs associated with high affinity and specificity with the target site in the γ-globin gene promoter. We delivered the -567Gγ ZF-DBDs directly to primary erythroid cells. Exposure of these cells to the recombinant -567Gγ ZF-DBDs led to increased expression of the γ-globin gene. Direct protein delivery of ZF-DBDs that compete with transcription regulatory proteins will have broad implications for modulating gene expression in analytical or therapeutic settings.

SELECTION OF CITATIONS
SEARCH DETAIL
...